Pharmaceutical Industry

Page 94 of 100

Lincoln Continental To Be Phased Out
Features

Greece tries again and Ford brings back the Lincoln Continental — 5 things to know today

By
March 30, 2015
Walgreens workers no longer want you to ‘Be Well’
Retail

Walgreens workers no longer want you to ‘Be Well’

By
March 26, 2015
Where do CEOs with addictions go when they hit bottom?
Leadership

Where do CEOs with addictions go when they hit bottom?

By
March 25, 2015
Merck
Features

Merck halts study in light of melanoma drug’s success

By
March 24, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features

Novartis unit hit with $110 million gender discrimination suit

By
March 17, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance

Valeant comes out a winner after upping its Salix bid to $11.1 billion

By
March 16, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
Retail

Spring must be here! J&J sues Glaxo over allergy cure claims

By
March 13, 2015
Stefano Pessina, Executive Deputy Chairm
Retail

Is Walgreens about to go shopping again?

By Reuters and Fortune Editors
March 12, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance

Endo International makes competing bid for Salix Pharmaceuticals

By
March 11, 2015
Biotech pros’ top 8 stock picks
Tech

Biotech pros’ top 8 stock picks

By
March 9, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features

FDA approves the first biosimilar for the U.S. market

By
March 6, 2015
IL: Corporations In Illinois
Features

AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation’?

By
March 5, 2015
China stock market
Features

China cuts growth and a big pharma deal — 5 things to know today

By
March 5, 2015
IL: Corporations In Illinois
Finance

AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal

By
March 5, 2015
Inside of a Gilead Sciences Lab
Tech

Is the future of pharma about making good drugs great?

By
February 27, 2015

Most Popular